- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07946471
A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health Outcomes
This is a single-group, open-label, decentralized clinical trial evaluating the effects of 6 weeks of daily Glow Shakes Premium Collagen Meal Replacement consumption on body composition, weight management, and self-reported health outcomes in 40 adults aged 18-55 years with a BMI between 25-35 kg/m².
All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily, replacing two typical meals, for 6 consecutive weeks. Assessments will be conducted at Baseline, Week 2, Week 4, and Week 6 and will include validated self-report questionnaires and body composition measurements via the Withings smart scale. All study activities are conducted remotely; products are shipped directly to participants' homes and all data are submitted digitally through the Citruslabs study platform.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Izaak Woodley
- E-mail: izaakwoodley@thecollagen.co
Lieux d'étude
-
-
Nevada
-
Las Vegas, Nevada, États-Unis, 89101
- Citruslabs
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Adults aged 18-55 years at the time of enrollment.
- BMI between 25-35 kg/m² at screening, as confirmed via participant self-report and/or Withings smart scale measurement at Baseline.
- Self-reported goals around weight management, body composition improvement, or overall health and wellness at the time of enrollment.
- Willing and able to use Glow Shakes Premium Collagen Meal Replacement as a daily meal replacement (replacing two typical meals) for 6 consecutive weeks and to complete all questionnaire assessments and Withings smart scale body composition measurements at Baseline, Week 2, Week 4, and Week 6.
- Willing to maintain current diet (except for the test product), exercise routine, and lifestyle habits for the duration of the 6-week study, without introducing any new supplements or products specifically targeting weight loss, appetite, or body composition.
- In good general health.
- Resides in the United States.
Exclusion Criteria:
- Pregnant or breastfeeding at the time of enrollment, or planning to become pregnant during the 6-week study period.
- Currently using GLP-1 receptor agonists, dual-incretin medications, prescription weight loss drugs, or any other prescription medication directly affecting appetite or body weight.
- Known allergy or intolerance to any ingredient in the Glow Shakes formulation, including milk protein, whey protein, or collagen-derived (bovine) ingredients.
- Diagnosed with a serious medical condition requiring medical nutritional management, including but not limited to Type 1 diabetes, active cancer, or severe renal or hepatic disease.
- Currently testing, or plan to in the next 6 weeks, a product for another research study.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Glow Shakes Premium Collagen Meal Replacement Arm
|
All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily (replacing two meals) for 6 weeks. Assessments will be conducted at four timepoints: Baseline, Week 2, Week 4, and Week 6. Assessments will include validated self-report questionnaires and body composition measurements via the Withings smart scale. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Body Weight
Délai: Baseline to Week 6
|
Change in body weight (kg) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home) |
Baseline to Week 6
|
|
Change in Body Fat Percentage
Délai: Baseline to Week 6
|
Change in body fat percentage (%) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home) |
Baseline to Week 6
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Self-Reported Weight Management Score
Délai: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported weight management scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Hunger Intensity
Délai: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported hunger intensity as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Satiety Duration
Délai: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported satiety duration as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Food Craving Score
Délai: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported food craving scores as assessed via the Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced) |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Skin Health Score
Délai: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported skin health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Hair Health Score
Délai: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported hair health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Nail Health Score
Délai: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported nail health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Gut Comfort and Digestive Symptom Score
Délai: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported gut comfort and digestive symptom scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Participant-Reported Product Satisfaction
Délai: Week 6
|
Participant-reported product satisfaction, acceptability, and tolerability as assessed via product satisfaction questionnaire |
Week 6
|
|
Participant-Reported Product Tolerability
Délai: Week 6
|
Participant-reported tolerability of the study product as assessed via product satisfaction questionnaire |
Week 6
|
|
Participant-Reported Overall Product Experience
Délai: Week 6
|
Participant-reported overall experience with the study product as assessed via product satisfaction questionnaire |
Week 6
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- THECO-22384
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .